Therefore, by blocking VEGF binding to receptors, the vascular system may be restored to a more “normal” state, decreasing blood vessel density and inhibiting the creation of new blood vessels, thus reducing tumor morbidity and mortality (Lopes-Coelho et al., 2021). Here, VEGFA is linked to neoplasm.